Clinical Trial Update: Study to Assess the Absorption, Distribution, Metabolism and Excretion of AZD1656 in Type 2 Diabetes Mellitus (T2DM) [Phase 1]

View source ↗

Summary

Phase 1 study from AstraZeneca assessing absorption, distribution, metabolism, and excretion of AZD1656 in individuals with Type 2 diabetes mellitus; the trial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• AZD1656

Snippet

Sponsor: AstraZeneca | Conditions: Type II Diabetes Mellitus | Phase 1 | Status: COMPLETED